Intech Investment Management LLC Acquires Shares of 12,393 Definitive Healthcare Corp. (NASDAQ:DH)

Intech Investment Management LLC purchased a new stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) during the third quarter, HoldingsChannel.com reports. The firm purchased 12,393 shares of the company’s stock, valued at approximately $55,000.

A number of other large investors have also recently made changes to their positions in DH. Millennium Management LLC purchased a new position in Definitive Healthcare during the 2nd quarter valued at about $9,283,000. Massachusetts Financial Services Co. MA grew its holdings in shares of Definitive Healthcare by 28.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,426,420 shares of the company’s stock worth $24,168,000 after acquiring an additional 976,279 shares during the period. 272 Capital LP purchased a new position in shares of Definitive Healthcare in the second quarter worth approximately $3,480,000. Marshall Wace LLP bought a new stake in shares of Definitive Healthcare during the 2nd quarter valued at $1,535,000. Finally, Algert Global LLC bought a new position in shares of Definitive Healthcare in the second quarter worth about $1,265,000. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Price Performance

NASDAQ DH opened at $4.66 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The stock’s fifty day moving average price is $4.39 and its 200 day moving average price is $4.74. The company has a market cap of $538.32 million, a price-to-earnings ratio of -1.50, a PEG ratio of 3.51 and a beta of 1.40. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on DH shares. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Definitive Healthcare currently has an average rating of “Hold” and an average target price of $5.81.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 14.84% of the company’s stock.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.